| Vol. 15.31 – 18 August, 2023 |
| |
|
|
| Scientists found that treatment with αCTLA-4, but not αPD-1, prolonged survival in a mouse model of mesenchymal-like glioblastoma. [Immunity] |
|
|
|
|
PUBLICATIONSRanked by the impact factor of the journal |
|
|
|
| Investigators described the drainage hierarchy of the pancreas, liver, and the upper small intestine into three murine lymph nodes. [Immunity] |
|
|
|
| Researchers uncovered host tolerance and resistance mechanisms that allowed Firmicutes from the human microbiota to control systemic immunity without inducing immunopathology. [Cell Host & Microbe] |
|
|
|
| The authors showed that short-term reiterative switching to ‘feast diets’, mimicking our social eating behavior, breached the potential buffering effect of the intestinal microbiota and reorganized the immunological architecture of mucosa-associated lymphoid tissues. [Nature Immunology] |
|
|
|
| Scientists compared the cellular, molecular, and functional outcome following cardiomyocyte transplantation in wildtype and T cell- and B cell-deficient Rag2del mice. [Genome Medicine] |
|
|
|
| In mice lacking dendritic intraepidermal γδ T cells or lacking IFNγR solely on γδ cells, allergic contact dermatitis (ACD)-elicited CD8 T cells showed enhanced proliferative and effector potentials and reduced motility, collectively associated with exaggerated ACD pathology. [Journal Of Allergy And Clinical Immunology] |
|
|
|
| Researchers showed that NLRP3 was ubiquitinated by the mitochondria-associated E3 ligase, MARCH5. [EMBO Journal] |
|
|
|
| Investigators carried out colitis and psoriasis models to evaluate the function of Tregs induced by helminth-derived peptide in vivo. [Ebiomedicine] |
|
|
|
| SOCS3 knockdown in human chimeric antigen receptor T cells exhibited a strong anti-tumor response in humanized mice. [Cell Reports] |
| |
|
|
|
| The authors outline recently developed organ-on-a-chip platforms and discuss the features needed for reliable prediction of sensitizing allergenicity of proteins. [Trends In Biotechnology] |
|
|
|
|
| AlloNK is a non-genetically modified, cord blood-derived, allogeneic, cryopreserved natural killer cell therapy candidate designed to enhance antibody-dependent cellular cytotoxicity. [Artiva Biotherapeutics Inc.] |
|
|
|
|
| September 20 – 23, 2023 EMBL Heidelberg and Virtual |
|
|
|
|
|
| University of Missouri – Columbia, Missouri, United States |
|
|
|
| Technical University of Denmark – Kongens Lyngby, Denmark |
|
|
|
| The University of Copenhagen – Copenhagen, Denmark |
|
|
|
| Harvard Medical School – Boston, Massachusetts, United States |
|
|
|
| Stanford University – Stanford, California, United States |
|
|
|
|